Thank you for downloading this publication. Please let us know why you chose this publication:
Why are you interested in this publication?
What organisation do you represent?
You will only need to complete this form once per browser/device
How do you prefer to read or receive publications?

We may contact you for feedback on the publication you have downloaded. If you do not want to be contacted, please leave the email field blank. Your information will never be shared with any third party.

Malaria Consortium US Donate
  • About us
    • Who we are
    • Our Strategy
    • Governance
    • Aid transparency
  • Projects
  • Where We Work
  • What we do
    • Diseases
    • Our responses
    • Burden reduction to elimination
    • Data-informed decision-making & digital approaches
    • Health sector resilience
    • Research & policy change
    • Networks & partnerships
  • News & Resources
    • News
    • Blog
    • Videos
    • Webinars
    • Photo stories
  • Publications
    • Interactive publications
  • Support us
  • Contact Us
    • Newsletter
  • Work with us
    • Tenders
  • Home
  • »
  • Publications
  • »
  • Feasibility and acceptability of extending seasonal malaria chemoprevention to children aged 5–10 years

Share this page

Resources

Latest

Publications

Publication Date:
15/07/2021

Type:
Research brief
Publication

Feasibility and acceptability of extending seasonal malaria chemoprevention to children aged 5–10 years

Publication Date:
15/07/2021
Type:
Research brief

Malaria is endemic in Chad, with a prevalence of around 41 percent in 2017. The World Health Organization recommends seasonal malaria chemoprevention (SMC) for children 3–59 months in areas of highly seasonal transmission across the Sahel. Routine household surveys conducted to evaluate coverage and quality of SMC delivery in Chad found that sulfadoxine-pyrimethamine and amodiaquine administration to children over 59 months appears to be common. 

Click here to download


Other Languages:

Télécharger en français

Country: Chad

Keywords: Capacity development | Community delivery | Malaria | Maternal, neonatal and child health | Preventive treatments | Seasonal malaria chemoprevention | SDG3

 

 

« Back to Publications

Sign up for our newsletter here:

Follow us on our social channels
  • Jobs
  • Contact us
  • Annual reviews
  • Support us
  • About us
  • Sitemap
  • Policies
  • Modern Slavery Statement
Fundraising Regulator logo
© 2023 Malaria Consortium | Charity No. 1099776 | Company No. 4785712